Spots Global Cancer Trial Database for p63
Every month we try and update this database with for p63 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | NCT01466504 | Renal Cell Carc... Hepatocellular ... Colorectal Carc... | skin punch biop... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | NCT01466504 | Renal Cell Carc... Hepatocellular ... Colorectal Carc... | skin punch biop... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | NCT01466504 | Renal Cell Carc... Hepatocellular ... Colorectal Carc... | skin punch biop... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | NCT01466504 | Renal Cell Carc... Hepatocellular ... Colorectal Carc... | skin punch biop... | 18 Years - | Dartmouth-Hitchcock Medical Center |